Cargando…

Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease

BACKGROUND: Huntington's disease (HD) is one of several neurodegenerative disorders that have been associated with metabolic alterations. Changes in Insulin Growth Factor 1 (IGF-1) and/or insulin input to the brain may underlie or contribute to the progress of neurodegenerative processes. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salem, Linda, Saleh, Nadine, Désaméricq, Gaelle, Youssov, Katia, Dolbeau, Guillaume, Cleret, Laurent, Bourhis, Marie-Laure, Azulay, Jean-Philippe, Krystkowiak, Pierre, Verny, Christophe, Morin, Françoise, Moutereau, Stéphane, Bachoud-Lévi, Anne-Catherine, Maison, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023180/ https://www.ncbi.nlm.nih.gov/pubmed/27627435 http://dx.doi.org/10.1371/journal.pone.0162890

Ejemplares similares

Neuroendocrine Disturbances in Huntington's Disease
por: Saleh, Nadine, et al.
Publicado: (2009)

Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort
por: Désaméricq, Gaëlle, et al.
Publicado: (2014)

How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease
por: Schramm, Catherine, et al.
Publicado: (2015)

Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease
por: Lemercier, Pablo, et al.
Publicado: (2022)

Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting
por: Cleret de Langavant, Laurent, et al.
Publicado: (2015)

COMT Val(158)Met Polymorphism Modulates Huntington's Disease Progression
por: de Diego-Balaguer, Ruth, et al.
Publicado: (2016)

Predicting clinical scores in Huntington’s disease: a lightweight speech test
por: Riad, Rachid, et al.
Publicado: (2022)

Cognitive decline in Huntington’s disease in the Digitalized Arithmetic Task (DAT)
por: Lunven, Marine, et al.
Publicado: (2021)

Awareness of Memory Deficits in Early Stage Huntington's Disease
por: Cleret de Langavant, Laurent, et al.
Publicado: (2013)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes
por: Mangin, Jean-Francois, et al.
Publicado: (2020)

The specific role of the striatum in interval timing: The Huntington’s disease model
por: Lemoine, Laurie, et al.
Publicado: (2021)

Alloimmunisation to Donor Antigens and Immune Rejection Following Foetal Neural Grafts to the Brain in Patients with Huntington's Disease
por: Krystkowiak, Pierre, et al.
Publicado: (2007)

Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

Corrigendum: Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington’s disease
por: Lunven, Marine, et al.
Publicado: (2023)

Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward
por: Bachoud‐Lévi, Anne‐Catherine, et al.
Publicado: (2020)

Approximating dementia prevalence in population‐based surveys of aging worldwide: An unsupervised machine learning approach
por: Cleret de Langavant, Laurent, et al.
Publicado: (2020)

Cognitive processes of apathy in Huntington’s disease show high sensitivity to disease progression
por: Hare, Emily, et al.
Publicado: (2022)

Behavioral and Neural Correlates of Communication via Pointing
por: Cleret de Langavant, Laurent, et al.
Publicado: (2011)

Identification of high likelihood of dementia in population-based surveys using unsupervised clustering: a longitudinal analysis
por: Gharbi-Meliani, Amin, et al.
Publicado: (2023)

Movement decline across lifespan of Caenorhabditis elegans mutants in the insulin/insulin‐like signaling pathway
por: Newell Stamper, Breanne L., et al.
Publicado: (2017)

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
por: Zuccato, Chiara, et al.
Publicado: (2011)

Insulin sensitivity predicts cognitive decline in individuals with prediabetes
por: Willmann, Caroline, et al.
Publicado: (2020)

SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients
por: Malkhasyan, Victoria, et al.
Publicado: (2019)

Identification of High Likelihood of Dementia in Population-Based Surveys using Unsupervised Clustering: a Longitudinal Analysis
por: Gharbi-Meliani, Amin, et al.
Publicado: (2023)

Association Between Insulin‐Like Growth Factor‐1 and Social Cognition in Huntington's Disease
por: Gil‐Polo, Cecilia, et al.
Publicado: (2022)

Respiratory decline is integral to disease progression in Huntington's disease
por: Jones, Una, et al.
Publicado: (2016)

Successful Cognitive Aging: Between Functional Decline and Failure of Compensatory Mechanisms
por: Verny, Marc, et al.
Publicado: (2015)

Insulin resistance and obesity: how do they affect tau pathology?
por: Gratuze, Maud, et al.
Publicado: (2013)

Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Dose comparison of ultrasonic transdermal insulin delivery to subcutaneous insulin injection
por: Park, Eun-Joo, et al.
Publicado: (2008)

Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline
por: Spinelli, Matteo, et al.
Publicado: (2019)

Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals
por: Nakamura, Suguru, et al.
Publicado: (2021)

Central insulin‐like growth factor‐1 (IGF‐1) restores whole‐body insulin action in a model of age‐related insulin resistance and IGF‐1 decline
por: Huffman, Derek M., et al.
Publicado: (2015)

Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance
por: Poher, Anne-Laure, et al.
Publicado: (2015)

Objectively characterizing Huntington’s disease using a novel upper limb dexterity test
por: Woodgate, Samuel, et al.
Publicado: (2021)

Brain-specific Proteins Decline in the Cerebrospinal Fluid of Humans with Huntington Disease
por: Fang, Qiaojun, et al.
Publicado: (2009)

Fetal striatal grafting slows motor and cognitive decline of Huntington's disease
por: Paganini, Marco, et al.
Publicado: (2014)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tolu86hikr8s28cmi14m4vva74